These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 24658549
1. The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis. Liu Y, Wang Z, Zhang B. Ann Saudi Med; 2014; 34(1):12-7. PubMed ID: 24658549 [Abstract] [Full Text] [Related]
2. Association between monoamine oxidase B A644G polymorphism and Parkinson's disease risk: a meta-analysis in the Chinese population. Liu JJ, Wang W, Meng M, Liang CS, Zhang JW. Genet Mol Res; 2016 Jul 14; 15(2):. PubMed ID: 27421021 [Abstract] [Full Text] [Related]
3. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Hernán MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Neurology; 2002 May 14; 58(9):1381-7. PubMed ID: 12011284 [Abstract] [Full Text] [Related]
4. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD. Zhang Y, Piao X, Wu J, Li Y, Liang Q. Int J Neurosci; 2016 May 14; 126(5):400-7. PubMed ID: 26000819 [Abstract] [Full Text] [Related]
5. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG. Mov Disord; 1999 Mar 14; 14(2):219-24. PubMed ID: 10091612 [Abstract] [Full Text] [Related]
6. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Kang SJ, Scott WK, Li YJ, Hauser MA, van der Walt JM, Fujiwara K, Mayhew GM, West SG, Vance JM, Martin ER. Mov Disord; 2006 Dec 14; 21(12):2175-80. PubMed ID: 17044053 [Abstract] [Full Text] [Related]
7. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Wu RM, Cheng CW, Chen KH, Lu SL, Shan DE, Ho YF, Chern HD. Neurology; 2001 Feb 13; 56(3):375-82. PubMed ID: 11171904 [Abstract] [Full Text] [Related]
8. Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis. Sun YX, Wang XH, Xu AH, Zhao JH. J Neurol Sci; 2014 Oct 15; 345(1-2):97-105. PubMed ID: 25066260 [Abstract] [Full Text] [Related]
9. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease. Torkaman-Boutorabi A, Shahidi GA, Choopani S, Rezvani M, Pourkosary K, Golkar M, Zarrindast MR. Acta Neurobiol Exp (Wars); 2012 Oct 15; 72(3):272-82. PubMed ID: 23093014 [Abstract] [Full Text] [Related]
10. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population. Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J, Dabrowska E, Kubisiak M, Kłodowska-Duda G, Opala G. Eur Neurol; 2005 Oct 15; 53(2):68-73. PubMed ID: 15753616 [Abstract] [Full Text] [Related]
12. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group. BMC Neurol; 2011 Jul 25; 11():89. PubMed ID: 21781348 [Abstract] [Full Text] [Related]
13. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population. Torkaman-Boutorabi A, Ali Shahidi G, Choopani S, Reza Zarrindast M. Folia Neuropathol; 2012 Jul 25; 50(4):382-9. PubMed ID: 23319194 [Abstract] [Full Text] [Related]
14. Gene-gene interaction between FGF20 and MAOB in Parkinson disease. Gao X, Scott WK, Wang G, Mayhew G, Li YJ, Vance JM, Martin ER. Ann Hum Genet; 2008 Mar 25; 72(Pt 2):157-62. PubMed ID: 18205889 [Abstract] [Full Text] [Related]
15. A monoamine oxidase B gene variant and short-term antidepressant treatment response. Tadić A, Rujescu D, Müller MJ, Kohnen R, Stassen HH, Dahmen N, Szegedi A. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1370-7. PubMed ID: 17640790 [Abstract] [Full Text] [Related]
16. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease. Löhle M, Mangone G, Wolz M, Beuthien-Baumann B, Oehme L, van den Hoff J, Kotzerke J, Reichmann H, Corvol JC, Storch A. Mov Disord; 2018 Sep 01; 33(9):1496-1501. PubMed ID: 30216543 [Abstract] [Full Text] [Related]
17. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects. Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK. Indian J Biochem Biophys; 2013 Oct 01; 50(5):436-41. PubMed ID: 24772965 [Abstract] [Full Text] [Related]
20. Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease. Zhu ZG, Ai QL, Wang WM, Xiao ZC. Gene; 2013 Nov 15; 531(1):78-83. PubMed ID: 23916622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]